- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of the core of the study is to demonstrate that a single TRUS-guided intraprostatic injection of NX-1207 provides a long lasting therapeutic improvement of LUTS associated with benign prostatic hyperplasia (LUTS/BPH) in patients not adequately controlled by medical therapy with α-blockers, as assessed by a change from baseline in the International Prostate Symptom Score (IPSS) total score.
Critère d'inclusion
- LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA